Skip to main content

Table 1 Main characteristics of the studies included in the meta-analysis

From: The prognostic value of lncRNA SNHG6 in cancer patients

Authors Year Cancer HR (95% CI) Method No. Follow NOS
An et al. 2018 RCC 1.93 (1.23–3.05) RT-PCR 81 80 m 9
Li et al. 2018 CRC 2.57 (1.06–6.25) RT-PCR 74 NR 8
Meng et al. 2018 Glioma 1.65 (1.10–3.32) RT-PCR 71 60 m 9
Xu et al. 2019 CRC 2.48 (1.60–5.86) RT-PCR 120 NR 8
Yu et al. 2019 CRC 2.83 (1.20–8.36) RT-PCR 141 NR 8
  1. RCC renal cell carcinoma, CRC colorectal cancer, HR hazard ratio, 95% CI 95% confidence interval, NR no report